FDA Approves Drug for Treatment of Nocturnal Polyuria March 14, 2017 By Nicholas Hamm Noctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes. Uro Pipeline: FDA committee votes in favor of nocturia treatment approval November 01, 2016 By Ben Schwartz Other pipeline developments discussed in this article include the initiation of an intravesical bladder cancer study, a gel treatment for ED that has met its primary endpoint, a patent awarded for the first rechargeable implantable SNM along with some other advancements. Uro Pipeline: Bladder Ca drug-device combination begins second phase Ib trial August 30, 2016 By Ben Schwartz A bladder cancer drug-device combination, a localized prostate cancer agent, and a new surgical robot are among other treatments in the pipeline discussed in this round-up. Female Urology: SUFU launches clinical care pathway for OAB patients July 19, 2016 By Charles Bankhead Other female urology topics discussed at this year's AUA meeting include preoperative urodynamics for women undergoing prolapse surgery and a study on nocturia. Physical activity reduces men’s nocturia risk September 08, 2014 By Benjamin P. Saylor Physical activity lowers men’s risk of developing nocturia and should be recommended to patients with the condition, a leading men’s health expert and Urology Times Editorial Council member says. Best of AUA 2014: BPH/LUTS Richard K. Lee, MD, MBA, presents the take home messages on BPH/LUTS from the AUA annual meeting in Orlando, FL.